Damora Therapeutics Inc. (DMRA) Live Share Price, Invest From India

Damora Therapeutics Inc. Stock Performance

as on August 12, 2026 at 4:06 am IST

Day's Low
Day's High
$29.14
Day's Price Range
$30.50
$29.84
2.35%
Downside
2.21%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$29.84
100.00%
Downside
-100.00%
Upside

Damora Therapeutics Inc. share price movements today

Previous Close: $29.54
Open: $29.24
Volume: 121.3K
Day's Low - High: $29.14 - $30.50

Damora Therapeutics Inc. Historical Returns

1 Month Return: + 3.54 %
3 Month Return: + 21.26 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Damora Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Damora Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-1.755

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-89.51%

Damora Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Damora Therapeutics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Damora Therapeutics Inc.	NA	$1.8B	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$44.0B	669.41%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$125.7B	168.33%	28.91	35.00%	NA
Regeneron Pharmaceuticals Inc.	BUY	$80.8B	32.8%	19.42	27.87%	0.47000000000000003%

Indian Investors' Interest in Damora Therapeutics Inc. Stock

Search interest for Damora Therapeutics Inc. Stock has decreased by -42% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 12, 2026 to August 11, 2026

Change:-42% versus previous 30 day period

Damora Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-3	-2	-2	-3	-3	-201	-30
EBITDA	-3	-6	-2	-3	-3	-200	-27
Interest Expense	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-3	-6	-2	-3	-3	-200	-27
Income Tax Expense	0	0	0	0	-	0	0
Net Income	-3	-6	-2	-3	-3	-200	-27
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Damora Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-52	-61	-36	-16	-210
EBITDA	-51	-61	-37	-21	-209
Interest Expense	-	-	-	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-51	-61	-38	-21	-209
Income Tax Expense	-	-	-	0	0
Net Income	-51	-61	-38	-21	-209
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Damora Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-5	-5	-3	-6	-2	-3	-3	-200	-27
Operating Cash Flow	-5	-4	-3	-4	-2	-2	-2	0	-20
Investing Cash Flow	5	6	-	-	-	-	-	-17	-
Financing Cash Flow	-	-	-	-	-	-	-	266	295
Change in Cash	0	1	-3	-4	-2	-2	-2	250	275

Damora Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-36	-34	-51	-61	-38	-21	-209
Operating Cash Flow	-19	-38	-52	-42	-36	-18	-6
Investing Cash Flow	0	-	-48	12	22	11	-17
Financing Cash Flow	-	187	-	0	2	-	266
Change in Cash	-19	152	-101	-29	-11	-7	243

Global Institutional Holdings in Damora Therapeutics Inc.

Funds	Holdings
Fairmount Funds Management LLC	14.45%
State Street Corp	0.3%
FCPM III SERVICES BV	4.05%
Remedium Capital Partners, LLC	0.2%
RA Capital Management, LLC	3.98%

See all

Insights on Damora Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, DMRA has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 year, DMRA stock has moved up by 774.0%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 590.1% return, outperforming this stock by 642.8%

About Damora Therapeutics Inc.

Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.

Organisation	Damora Therapeutics Inc.
Headquarters	Building 23, Waltham, MA, United States, 02453
Industry	Biotechnology
CEO	Ms. Jennifer A. Jarrett M.B.A.
E-voting on shares	Click here to vote

Key Management of Damora Therapeutics Inc.

Name	Title
Mr. Ulf J. Nilsson Ph.D.	Co-Founder
Dr. Hakon Leffler M.D., Ph.D.	Co-Founder
Prof. Tariq Sethi B.Sc., FRCP, M.A., M.D., Ph.D.	Co-Founder
Mr. Brian Burkavage CPA	Senior VP of Finance, Principal Financial & Accounting Officer
Mr. Sherwin Sattarzadeh	Chief Operating Officer
Dr. Becker Hewes M.D.	Chief Medical Officer
Mr. Garrett Winslow Esq.	Senior VP, General Counsel & Corporate Secretary
Ms. Jennifer A. Jarrett M.B.A.	CEO, President & Director

FAQs

What is Damora Therapeutics Inc. share price today?

Damora Therapeutics Inc. share price today is $29.84 as on August 11, 2026 at 10:36 pm IST. Damora Therapeutics Inc. share today touched a day high of $30.50 and a low of $29.14.

What is the 52 week high and 52 week low for Damora Therapeutics Inc. share?

Damora Therapeutics Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Damora Therapeutics Inc. stock price today i.e. August 11, 2026 at 10:36 pm IST is trending at $29.84,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Damora Therapeutics Inc.'s market capitalisation today?

Damora Therapeutics Inc. market capitalisation is $0.00T as on August 11, 2026 at 10:36 pm IST.

How to invest in Damora Therapeutics Inc. Stock (DMRA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Damora Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Damora Therapeutics Inc. Shares that will get you 0.0503 shares as per Damora Therapeutics Inc. share price of $29.84 per share as on August 11, 2026 at 10:36 pm IST.

What is the minimum amount required to buy Damora Therapeutics Inc. Stock (DMRA) from India?

Indian investors can start investing in Damora Therapeutics Inc. (DMRA) shares with as little as ₹95.435 or $1 (as of August 11, 2026 at 10:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹954.35 in Damora Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on August 11, 2026 at 10:37 pm IST). Based on Damora Therapeutics Inc. share’s latest price of $29.84 as on August 11, 2026 at 10:36 pm IST, you will get 0.3351 shares of Damora Therapeutics Inc.. Learn more about fractional shares .